These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Development of anti-influenza A compounds: a pilot study. Zheng BJ; Chan CS; Poon KM; Ng F; Ho CM; Che CM; Yuen KY Hong Kong Med J; 2013 Jun; 19 Suppl 4():36-8. PubMed ID: 23775185 [TBL] [Abstract][Full Text] [Related]
26. Infection of human retinal pigment epithelial cells with influenza A viruses. Michaelis M; Geiler J; Klassert D; Doerr HW; Cinatl J Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5419-25. PubMed ID: 19553611 [TBL] [Abstract][Full Text] [Related]
27. Evaluation of intravenous zanamivir against experimental influenza A (H5N1) virus infection in cynomolgus macaques. Stittelaar KJ; Tisdale M; van Amerongen G; van Lavieren RF; Pistoor F; Simon J; Osterhaus AD Antiviral Res; 2008 Nov; 80(2):225-8. PubMed ID: 18647621 [TBL] [Abstract][Full Text] [Related]
28. Antiviral effect of a selective COX-2 inhibitor on H5N1 infection in vitro. Lee SM; Gai WW; Cheung TK; Peiris JS Antiviral Res; 2011 Sep; 91(3):330-4. PubMed ID: 21798291 [TBL] [Abstract][Full Text] [Related]
29. Cracking the code for H5N1-bird flu and beyond. Thomson RJ; Haselhorst T; Dyason JC; von Itzstein M Curr Drug Deliv; 2009 Aug; 6(4):343-6. PubMed ID: 19534713 [TBL] [Abstract][Full Text] [Related]
30. Antiviral activity of the proteasome inhibitor VL-01 against influenza A viruses. Haasbach E; Pauli EK; Spranger R; Mitzner D; Schubert U; Kircheis R; Planz O Antiviral Res; 2011 Sep; 91(3):304-13. PubMed ID: 21777621 [TBL] [Abstract][Full Text] [Related]
31. Low-dose interferon Type I treatment is effective against H5N1 and swine-origin H1N1 influenza A viruses in vitro and in vivo. Haasbach E; Droebner K; Vogel AB; Planz O J Interferon Cytokine Res; 2011 Jun; 31(6):515-25. PubMed ID: 21323570 [TBL] [Abstract][Full Text] [Related]
32. The threat of avian influenza A (H5N1). Part III: Antiviral therapy. Cinatl J; Michaelis M; Doerr HW Med Microbiol Immunol; 2007 Dec; 196(4):203-12. PubMed ID: 17431677 [TBL] [Abstract][Full Text] [Related]
33. A polyphenol rich plant extract, CYSTUS052, exerts anti influenza virus activity in cell culture without toxic side effects or the tendency to induce viral resistance. Ehrhardt C; Hrincius ER; Korte V; Mazur I; Droebner K; Poetter A; Dreschers S; Schmolke M; Planz O; Ludwig S Antiviral Res; 2007 Oct; 76(1):38-47. PubMed ID: 17572513 [TBL] [Abstract][Full Text] [Related]
34. Structure-activity relationships of saponin derivatives: a series of entry inhibitors for highly pathogenic H5N1 influenza virus. Ding N; Chen Q; Zhang W; Ren S; Guo Y; Li Y Eur J Med Chem; 2012 Jul; 53():316-26. PubMed ID: 22575533 [TBL] [Abstract][Full Text] [Related]
35. (-)-Carbodine: enantiomeric synthesis and in vitro antiviral activity against various strains of influenza virus including H5N1 (avian influenza) and novel 2009 H1N1 (swine flu). Rao JR; Jha AK; Rawal RK; Sharon A; Day CW; Barnard DL; Smee DF; Chu CK Bioorg Med Chem Lett; 2010 Apr; 20(8):2601-4. PubMed ID: 20231094 [TBL] [Abstract][Full Text] [Related]
36. Inhibitory effects of epigallocatechin gallate (EGCG) combined with zinc sulfate and silver nanoparticles on avian influenza A virus subtype H5N1. Saadh MJ; Aldalaen SM Eur Rev Med Pharmacol Sci; 2021 Mar; 25(6):2630-2636. PubMed ID: 33829450 [TBL] [Abstract][Full Text] [Related]
37. Highly pathogenic H5N1 avian influenza virus: cause of the next pandemic? Pappaioanou M Comp Immunol Microbiol Infect Dis; 2009 Jul; 32(4):287-300. PubMed ID: 19318178 [TBL] [Abstract][Full Text] [Related]
38. Human infection with highly pathogenic avian influenza A (H5N1) virus: review of clinical issues. Uyeki TM Clin Infect Dis; 2009 Jul; 49(2):279-90. PubMed ID: 19522652 [TBL] [Abstract][Full Text] [Related]
39. In vitro and in vivo protection against the highly pathogenic H5N1 influenza virus by an antisense phosphorothioate oligonucleotide. Duan M; Zhou Z; Lin RX; Yang J; Xia XZ; Wang SQ Antivir Ther; 2008; 13(1):109-14. PubMed ID: 18389905 [TBL] [Abstract][Full Text] [Related]
40. Influenza A H5N1 clade 2.3.4 virus with a different antiviral susceptibility profile replaced clade 1 virus in humans in northern Vietnam. Le MT; Wertheim HF; Nguyen HD; Taylor W; Hoang PV; Vuong CD; Nguyen HL; Nguyen HH; Nguyen TQ; Nguyen TV; Van TD; Ngoc BT; Bui TN; Nguyen BG; Nguyen LT; Luong ST; Phan PH; Pham HV; Nguyen T; Fox A; Nguyen CV; Do HQ; Crusat M; Farrar J; Nguyen HT; de Jong MD; Horby P PLoS One; 2008 Oct; 3(10):e3339. PubMed ID: 18836532 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]